These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 2587939)
1. The outcome of Pneumocystis carinii pneumonia in Danish patients with AIDS. Pedersen C; Lundgren JD; Nielsen T; Andersen WH Scand J Infect Dis; 1989; 21(4):375-80. PubMed ID: 2587939 [TBL] [Abstract][Full Text] [Related]
2. Trimethoprim-sulphamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS. Carr A; Tindall B; Penny R; Cooper DA AIDS; 1992 Feb; 6(2):165-71. PubMed ID: 1558714 [TBL] [Abstract][Full Text] [Related]
3. Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases. Kitazawa T; Seo K; Yoshino Y; Asako K; Kikuchi H; Kono H; Ota Y J Infect Chemother; 2019 May; 25(5):351-354. PubMed ID: 30711257 [TBL] [Abstract][Full Text] [Related]
4. Rapid oral desensitization to trimethoprim-sulfamethoxazole (TMP-SMZ): use in prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant to TMP-SMZ. Gluckstein D; Ruskin J Clin Infect Dis; 1995 Apr; 20(4):849-53. PubMed ID: 7795084 [TBL] [Abstract][Full Text] [Related]
5. Pneumocystis carinii pneumonia and its treatment in patients with AIDS. Gazzard BG J Antimicrob Chemother; 1989 Jan; 23 Suppl A():67-75. PubMed ID: 2654117 [TBL] [Abstract][Full Text] [Related]
6. Trimethoprim-sulfamethoxazole versus pentamidine for Pneumocystis carinii pneumonia in AIDS patients: results of a large prospective randomized treatment trial. Klein NC; Duncanson FP; Lenox TH; Forszpaniak C; Sherer CB; Quentzel H; Nunez M; Suarez M; Kawwaff O; Pitta-Alvarez A AIDS; 1992 Mar; 6(3):301-5. PubMed ID: 1567574 [TBL] [Abstract][Full Text] [Related]
7. Use of trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonitis in patients with acquired immunodeficiency syndrome. Wofsy CB Rev Infect Dis; 1987; 9 Suppl 2():S184-94. PubMed ID: 3554457 [TBL] [Abstract][Full Text] [Related]
8. Treatment of Pneumocystis carinii pneumonia in patients with AIDS. Wordell CJ; Hauptman SP Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063 [TBL] [Abstract][Full Text] [Related]
9. Pneumocystis carinii pneumonia in Stockholm, Sweden: treatment, outcome, one-year-follow-up and pyrimethamine prophylaxis. Lidman C; Ortqvist A; Lundbergh P; Julander I; Bergdahl S Scand J Infect Dis; 1989; 21(4):381-7. PubMed ID: 2587940 [TBL] [Abstract][Full Text] [Related]
10. Low-dose co-trimoxazole for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus disease. Ruskin J; LaRiviere M Lancet; 1991 Feb; 337(8739):468-71. PubMed ID: 1671479 [TBL] [Abstract][Full Text] [Related]
11. Three cases of acquired immunodeficiency syndrome complicated with toxic epidermal necrolysis. Kimura S; Oka S; Mohri H; Mitamura K; Shimada K Jpn J Med; 1991; 30(6):553-8. PubMed ID: 1798215 [TBL] [Abstract][Full Text] [Related]
13. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group. Chaisson RE; Keruly J; Richman DD; Moore RD Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373 [TBL] [Abstract][Full Text] [Related]
14. Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a prospective, randomized, controlled clinical trial. LFPMI Study Group. Ligue Française de Prévention des Maladies Infectieuses. May T; Beuscart C; Reynes J; Marchou B; Leclercq P; Borsa Lebas F; Saba J; Micoud M; Mouton Y; Canton P J Acquir Immune Defic Syndr (1988); 1994 May; 7(5):457-62. PubMed ID: 8158539 [TBL] [Abstract][Full Text] [Related]
15. Randomized study of sulfamethoxazole-trimethoprim versus aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS. Nielsen TL; Jensen BN; Nelsing S; Mathiesen LR; Skinhøj P; Nielsen JO Scand J Infect Dis; 1995; 27(3):217-20. PubMed ID: 8539544 [TBL] [Abstract][Full Text] [Related]
16. Cost and benefit of secondary prophylaxis for Pneumocystis carinii pneumonia. Castellano AR; Nettleman MD JAMA; 1991 Aug; 266(6):820-4. PubMed ID: 1907671 [TBL] [Abstract][Full Text] [Related]
17. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus. MMWR Recomm Rep; 1992 Apr; 41(RR-4):1-11. PubMed ID: 1348843 [TBL] [Abstract][Full Text] [Related]
18. Decisions in P. carinii pneumonia. Frank I; MacGregor RR Hosp Pract (Off Ed); 1990 Apr; 25(4A):8, 13-4. PubMed ID: 2109757 [No Abstract] [Full Text] [Related]
19. A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients. Martin MA; Cox PH; Beck K; Styer CM; Beall GN Arch Intern Med; 1992 Mar; 152(3):523-8. PubMed ID: 1546914 [TBL] [Abstract][Full Text] [Related]
20. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole. Fisher RG; Nageswaran S; Valentine ME; McKinney RE AIDS Patient Care STDS; 2001 May; 15(5):263-9. PubMed ID: 11530767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]